Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients
Goldberg DS, Abt PL, Blumberg EA, Van Deerlin VM, Levine M, Reddy KR, Bloom RD, Nazarian SM, Sawinski D, Porrett P, Naji A, Hasz R, Suplee L, Trofe-Clark J, Sicilia A, McCauley M, Farooqi M, Gentile C, Smith J, Reese PP. N Engl J Med. 2017 Apr 30. doi: 10.1056/NEJMc1705221. [Epub ahead of print]
Summary
Results of a clinical trial with the first 10 patients show that hepatitis C virus genotype 1–infected kidneys transplanted into HCV-negative recipients, followed by direct-acting antiviral therapy, can result in excellent allograft function with cure of HCV infection.
Read the Department of Communications news release.
